BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 16392434)

  • 21. [Artificial nutrition of patients with toxic epidermal necrolysis (Lyell syndrome)].
    Kertai M; Dárdai E; Telkes M; Nébenführer L
    Orv Hetil; 1997 Oct; 138(41):2609-11. PubMed ID: 9411331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of toxic epidermal necrolysis with lesions mostly on sun-exposed skin.
    Mansur AT; Aydingöz IA
    Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):100-2. PubMed ID: 15752129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute generalised exanthematous pustulosis and toxic epidermal necrolysis induced by carbamazepine.
    Goh TK; Pang SM; Thirumoorthy T; Goh SG
    Singapore Med J; 2008 Jun; 49(6):507-10. PubMed ID: 18581028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification.
    Wolf R; Matz H; Marcos B; Orion E
    Clin Dermatol; 2005; 23(3):311-4. PubMed ID: 15896547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of toxic epidermal necrolysis and related syndromes.
    Mukasa Y; Craven N
    Postgrad Med J; 2008 Feb; 84(988):60-5. PubMed ID: 18322124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cutaneous side effects due to psychiatric drugs].
    Rebok F; Pérez Roldán ML; Daray FM
    Vertex; 2008; 19(82):348-56. PubMed ID: 19424517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case report: psychosis with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    de Rego JA; Goldstein DM
    Hillside J Clin Psychiatry; 1985; 7(2):141-8. PubMed ID: 4077031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.
    Halevy S; Ghislain PD; Mockenhaupt M; Fagot JP; Bouwes Bavinck JN; Sidoroff A; Naldi L; Dunant A; Viboud C; Roujeau JC;
    J Am Acad Dermatol; 2008 Jan; 58(1):25-32. PubMed ID: 17919772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Norfloxacin-induced toxic epidermal necrolysis.
    Sahin MT; Ozturkcan S; Inanir I; Filiz EE
    Ann Pharmacother; 2005 Apr; 39(4):768-70. PubMed ID: 15713789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study.
    Lin MS; Dai YS; Pwu RF; Chen YH; Chang NC
    Intern Med J; 2005 Mar; 35(3):188-90. PubMed ID: 15737140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stevens-Johnson syndrome and toxic epidermal necrolysis induced by amifostine during head and neck radiotherapy.
    Valeyrie-Allanore L; Poulalhon N; Fagot JP; Sekula P; Davidovici B; Sidoroff A; Mockenhaupt M
    Radiother Oncol; 2008 May; 87(2):300-3. PubMed ID: 18328585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases.
    Abe R
    J Dermatol Sci; 2008 Dec; 52(3):151-9. PubMed ID: 18657400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stevens-Johnson syndrome and toxic epidermal necrolysis: consequence of treatment of an emerging pathogen.
    Mistry RD; Schwab SH; Treat JR
    Pediatr Emerg Care; 2009 Aug; 25(8):519-22. PubMed ID: 19687711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Toxic epidermal necrolysis during therapy with sulphasalazine in a patient with arthritis. Case report].
    Rachwał-Siek K; Ponikowska M; Wiland P
    Wiad Lek; 2011; 64(4):283-7. PubMed ID: 22533153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxic epidermal necrolysis.
    Edlich RF; Kenney JG; Nichter LS; Silloway KA; Horowitz JH
    Compr Ther; 1986 May; 12(5):43-9. PubMed ID: 3709103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole.
    Wanat KA; Anadkat MJ; Klekotka PA
    J Am Acad Dermatol; 2009 Apr; 60(4):589-94. PubMed ID: 19217690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rare case of streptomycin-induced toxic epidermal necrolysis in a patient with tuberculosis: a therapeutic dilemma.
    Hmouda H; Laouani-Kechrid C; Nejib Karoui M; Denguezli M; Nouira R; Ghannouchi G
    Ann Pharmacother; 2005 Jan; 39(1):165-8. PubMed ID: 15546942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serious and life-threatening drug eruptions.
    Manders SM
    Am Fam Physician; 1995 Jun; 51(8):1865-72. PubMed ID: 7762478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants.
    Wolkenstein P; Charue D; Laurent P; Revuz J; Roujeau JC; Bagot M
    Arch Dermatol; 1995 May; 131(5):544-51. PubMed ID: 7741540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Stevens-Johnson syndrome and toxic epidermal necrolysis after intake of rifampicin-isoniazid: report of 8 cases in HIV-infected patients in Togo].
    Pitche P; Mouzou T; Padonou C; Tchangai-Walla K
    Med Trop (Mars); 2005 Sep; 65(4):359-62. PubMed ID: 16548490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.